The nation’s largest gathering of private sector and academic scholars focused on developing new antimicrobial products. As bacterial resistance continues to grow globally, those investing in new antimicrobials gather to learn more about how to focus attention, reduce regulatory hurndles and increase funding to build the antibiotic pipeline. Speakers include officials from the Food and Drug Administration and the Biomedical Advanced Research and Development Authority.
Conference will be held at the Renaissance Hotel, 999 9th Street NW, Washington DC, 20001
Journalists reach out to: Sharon McGorry, 646-619-1840, Sharon.mcgorry@terrapin.com